Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Suppression of zinc finger protein 467 alleviates osteoporosis through promoting differentiation of adipose derived stem cells to osteoblasts

Authors: Li You, Ling Pan, Lin Chen, Jin-Yu Chen, Xiaoping Zhang, Zhongwei Lv, Da Fu

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Osteoblast and adipocyte are derived from common mesenchymal progenitor cells. The bone loss of osteoporosis is associated with altered progenitor differentiation from an osteoblastic to an adipocytic lineage. In this study, a comparative analysis of gene expression profiling using cDNA microarray and realtime-PCR indicated that Zinc finger protein 467 (Zfp467) involved in adipocyte and osteoblast differentiation of cultured adipose derived stem cells (ADSCs). Our results showed that RNA interference for Zfp467 in ADSCs inhibited adipocyte formation and stimulated osteoblast commitment. The mRNA levels of osteogenic and adipogenic markers in ADSCs were regulated by si-Zfp467. Zfp467 RNAi in ADSCs could restore bone function and structure in an ovariectomized (OVX)-induced osteoporotic mouse model. Thus Zfp467 play an important role in ADSCs differentiation to adipocyte and osteoblast. This has relevance to therapeutic interventions in osteoporosis, including si-Zfp467-based therapies currently available, and may be of relevance for the use of adipose-derived stem cells for tissue engineering.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford WL: Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA. 2003, 100: 5840-5845. 10.1073/pnas.1036475100.CrossRefPubMedPubMedCentral Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford WL: Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA. 2003, 100: 5840-5845. 10.1073/pnas.1036475100.CrossRefPubMedPubMedCentral
2.
go back to reference Wegrzyn J, Roux JP, Arlot ME, Boutroy S, Vilayphiou N, Guyen O, Delmas PD, Chapurlat R, Bouxsein ML: Role of trabecular microarchitecture and its heterogeneity parameters in the mechanical behavior of ex vivo human L3 vertebrae. J Bone Miner Res. 2010, 25: 2324-2331. 10.1002/jbmr.164.CrossRefPubMedPubMedCentral Wegrzyn J, Roux JP, Arlot ME, Boutroy S, Vilayphiou N, Guyen O, Delmas PD, Chapurlat R, Bouxsein ML: Role of trabecular microarchitecture and its heterogeneity parameters in the mechanical behavior of ex vivo human L3 vertebrae. J Bone Miner Res. 2010, 25: 2324-2331. 10.1002/jbmr.164.CrossRefPubMedPubMedCentral
3.
go back to reference Ammann P, Laib A, Bonjour JP, Meyer JM, Rüegsegger P, Rizzoli R: Dietary essential amino acid supplements increase bone strength by influencing bone mass and bone microarchitecture in ovariectomized adult rats fed an isocaloric low-protein diet. J Bone Miner Res. 2002, 17: 1264-1272. 10.1359/jbmr.2002.17.7.1264.CrossRefPubMed Ammann P, Laib A, Bonjour JP, Meyer JM, Rüegsegger P, Rizzoli R: Dietary essential amino acid supplements increase bone strength by influencing bone mass and bone microarchitecture in ovariectomized adult rats fed an isocaloric low-protein diet. J Bone Miner Res. 2002, 17: 1264-1272. 10.1359/jbmr.2002.17.7.1264.CrossRefPubMed
4.
go back to reference Kassem M, Abdallah BM: Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res. 2008, 331: 157-163. 10.1007/s00441-007-0509-0.CrossRefPubMed Kassem M, Abdallah BM: Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res. 2008, 331: 157-163. 10.1007/s00441-007-0509-0.CrossRefPubMed
5.
go back to reference Egermann M, Heil P, Tami A, Ito K, Janicki P, Von Rechenberg B, Hofstetter W, Richards PJ: Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis. J Orthop Res. 2010, 28: 798-804.PubMed Egermann M, Heil P, Tami A, Ito K, Janicki P, Von Rechenberg B, Hofstetter W, Richards PJ: Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis. J Orthop Res. 2010, 28: 798-804.PubMed
6.
go back to reference Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC: Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest. 1996, 97: 1732-1740. 10.1172/JCI118600.CrossRefPubMedPubMedCentral Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC: Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest. 1996, 97: 1732-1740. 10.1172/JCI118600.CrossRefPubMedPubMedCentral
7.
go back to reference Kodama Y, Takeuchi Y, Suzawa M, Fukumoto S, Murayama H, Yamato H, Fujita T, Kurokawa T, Matsumoto T: Reduced expression of interleukin-11 in bone marrow stromal cells of senescence accelerated mice (SAMP6): Relationship to osteopenia with enhanced adipogenesis. J Bone Miner Res. 1998, 13: 1370-1377. 10.1359/jbmr.1998.13.9.1370.CrossRefPubMed Kodama Y, Takeuchi Y, Suzawa M, Fukumoto S, Murayama H, Yamato H, Fujita T, Kurokawa T, Matsumoto T: Reduced expression of interleukin-11 in bone marrow stromal cells of senescence accelerated mice (SAMP6): Relationship to osteopenia with enhanced adipogenesis. J Bone Miner Res. 1998, 13: 1370-1377. 10.1359/jbmr.1998.13.9.1370.CrossRefPubMed
8.
go back to reference Chen TL: Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone. 2004, 35: 83-95. 10.1016/j.bone.2004.03.019.CrossRefPubMed Chen TL: Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone. 2004, 35: 83-95. 10.1016/j.bone.2004.03.019.CrossRefPubMed
9.
go back to reference Rodríguez JP, Astudillo P, Ríos S, Pino AM: Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther. 2008, 3: 208-218. 10.2174/157488808785740325.CrossRefPubMed Rodríguez JP, Astudillo P, Ríos S, Pino AM: Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther. 2008, 3: 208-218. 10.2174/157488808785740325.CrossRefPubMed
10.
go back to reference Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126/science.284.5411.143.CrossRefPubMed Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126/science.284.5411.143.CrossRefPubMed
11.
go back to reference Rodríguez JP, Garat S, Gajardo H, Pino AM, Seitz G: Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem. 1999, 75: 414-423. 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C.CrossRefPubMed Rodríguez JP, Garat S, Gajardo H, Pino AM, Seitz G: Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem. 1999, 75: 414-423. 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C.CrossRefPubMed
12.
go back to reference Rodríguez JP, Astudillo P, Ríos S, Pino AM: Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther. 2008, 3: 208-218. 10.2174/157488808785740325.CrossRefPubMed Rodríguez JP, Astudillo P, Ríos S, Pino AM: Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther. 2008, 3: 208-218. 10.2174/157488808785740325.CrossRefPubMed
13.
go back to reference Masiukiewicz US, Mitnick M, Grey AB, Insogna KL: Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro. Endocrinology. 2000, 141: 2526-2531. 10.1210/en.141.7.2526.PubMed Masiukiewicz US, Mitnick M, Grey AB, Insogna KL: Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro. Endocrinology. 2000, 141: 2526-2531. 10.1210/en.141.7.2526.PubMed
14.
go back to reference Mimeault M, Batra SK: Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 2008, 4: 27-49. 10.1007/s12015-008-9008-2.CrossRefPubMed Mimeault M, Batra SK: Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 2008, 4: 27-49. 10.1007/s12015-008-9008-2.CrossRefPubMed
15.
go back to reference Corre J, Barreau C, Cousin B, Chavoin JP, Caton D, Fournial G, Penicaud L, Casteilla L, Laharrague P: Human subcutaneous adipose cells support complete differentiation but not self-renewal of hematopoietic progenitors. J Cell Physiol. 2006, 208: 282-288. 10.1002/jcp.20655.CrossRefPubMed Corre J, Barreau C, Cousin B, Chavoin JP, Caton D, Fournial G, Penicaud L, Casteilla L, Laharrague P: Human subcutaneous adipose cells support complete differentiation but not self-renewal of hematopoietic progenitors. J Cell Physiol. 2006, 208: 282-288. 10.1002/jcp.20655.CrossRefPubMed
16.
go back to reference Mimeault M, Mehta PP, Hauke R, Batra SK: Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies. Endocr Rev. 2008, 29: 234-252.CrossRefPubMedPubMedCentral Mimeault M, Mehta PP, Hauke R, Batra SK: Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies. Endocr Rev. 2008, 29: 234-252.CrossRefPubMedPubMedCentral
17.
go back to reference Gimble JM, Nuttall ME: Adipose-derived stromal/stem cells (ASC) in regenerative medicine: pharmaceutical applications. Curr Pharm Des. 2011, 17: 332-339. 10.2174/138161211795164220.CrossRefPubMed Gimble JM, Nuttall ME: Adipose-derived stromal/stem cells (ASC) in regenerative medicine: pharmaceutical applications. Curr Pharm Des. 2011, 17: 332-339. 10.2174/138161211795164220.CrossRefPubMed
18.
go back to reference Quach JM, Walker EC, Allan E, Solano M, Yokoyama A, Kato S, Sims NA, Gillespie MT, Martin TJ: Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment. J Biol Chem. 2011, 286: 4186-4198. 10.1074/jbc.M110.178251.CrossRefPubMedPubMedCentral Quach JM, Walker EC, Allan E, Solano M, Yokoyama A, Kato S, Sims NA, Gillespie MT, Martin TJ: Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment. J Biol Chem. 2011, 286: 4186-4198. 10.1074/jbc.M110.178251.CrossRefPubMedPubMedCentral
19.
go back to reference Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7: 211-228. 10.1089/107632701300062859.CrossRefPubMed Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7: 211-228. 10.1089/107632701300062859.CrossRefPubMed
20.
go back to reference Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E: Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology. 2003, 144: 2588-2596. 10.1210/en.2002-221044.CrossRefPubMed Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E: Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology. 2003, 144: 2588-2596. 10.1210/en.2002-221044.CrossRefPubMed
21.
go back to reference Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y: v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006, 12: 1403-1409.CrossRefPubMed Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y: v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006, 12: 1403-1409.CrossRefPubMed
22.
go back to reference Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M: Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss. J Cell Physiol. 2008, 216: 47-53. 10.1002/jcp.21374.CrossRefPubMed Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M: Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss. J Cell Physiol. 2008, 216: 47-53. 10.1002/jcp.21374.CrossRefPubMed
24.
25.
go back to reference Papachroni KK, Karatzas DN, Papavassiliou KA, Basdra EK, Papavassiliou AG: Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med. 2009, 15: 208-216. 10.1016/j.molmed.2009.03.001.CrossRefPubMed Papachroni KK, Karatzas DN, Papavassiliou KA, Basdra EK, Papavassiliou AG: Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med. 2009, 15: 208-216. 10.1016/j.molmed.2009.03.001.CrossRefPubMed
26.
go back to reference Lien CY, Chih-Yuan Ho K, Lee OK, Blunn GW, Su Y: Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 2009, 24: 837-848. 10.1359/jbmr.081257.CrossRefPubMed Lien CY, Chih-Yuan Ho K, Lee OK, Blunn GW, Su Y: Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 2009, 24: 837-848. 10.1359/jbmr.081257.CrossRefPubMed
27.
go back to reference Lee K, Kim H, Kim JM, Kim JR, Kim KJ, Kim YJ, Park SI, Jeong JH, Moon YM, Lim HS, Bae DW, Kwon J, Ko CY, Kim HS, Shin HI, Jeong D: Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. J Cell Mol Med. 2011, 15: 2082-2094. 10.1111/j.1582-4934.2010.01230.x.CrossRefPubMedPubMedCentral Lee K, Kim H, Kim JM, Kim JR, Kim KJ, Kim YJ, Park SI, Jeong JH, Moon YM, Lim HS, Bae DW, Kwon J, Ko CY, Kim HS, Shin HI, Jeong D: Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. J Cell Mol Med. 2011, 15: 2082-2094. 10.1111/j.1582-4934.2010.01230.x.CrossRefPubMedPubMedCentral
Metadata
Title
Suppression of zinc finger protein 467 alleviates osteoporosis through promoting differentiation of adipose derived stem cells to osteoblasts
Authors
Li You
Ling Pan
Lin Chen
Jin-Yu Chen
Xiaoping Zhang
Zhongwei Lv
Da Fu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-11

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.